search
Company Information
USD
4.71
- (0.9%)
NASDAQ:QURE, UNIQURE N.V.
Industry: Biotechnology
End of Day: 18 April 2024 GMT-4
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Address

Paasheuvelweg 25

Classification

Sector

Healthcare

Industry Group

Biotechnology

Industry

Biotechnology

Key Executives

Mr. Jack L. Kaye
Director
Dr. Leonard E. Post, PhD
Director
Mr. Matthew C. Kapusta
CEO/Director
Mr. David D. Meek
Chairman of the Board/Director
Ms. Paula Soteropoulos
Director
Mr. Madhavan Balachandran
Director
Mr. Christian Klemt
CFO/Chief Accounting Officer/General Manager, Subsidiary
Dr. Jeremy P. Springhorn, PhD
Director
Dr. Robert Gut, M.D.,PhD
Director
Ms. Rachelle Jacques
Director
Dr. Richard Porter, PhD
Chief Scientific Officer/Other Executive Officer
Mr. Pierre Caloz
COO

Ownership

Institution Holdings

Nantahala Capital Management, LLC
5,916,054 (12.367%)
SSGA Funds Management Inc
3,538,827 (7.397%)
State Street Corporation
3,478,872 (7.272%)
FMR LLC
2,700,927 (5.649%)
PFM Health Sciences, LP
2,302,314 (4.815%)
BlackRock Inc
1,836,696 (3.839%)
Morgan Stanley - Brokerage Accounts
1,759,818 (3.679%)
683 Capital Management LLC
1,693,000 (3.539%)
Goldman Sachs Group Inc
1,390,690 (2.907%)
Orbimed Advisors, LLC
1,347,900 (2.818%)

Individual Holdings

Mr. Matthew C. Kapusta
590,839 (1.235%)
Mr. Christian Klemt
166,448 (0.348%)
Mr. Jonathan Garen
93,638 (0.299%)
Mr. Pierre Caloz
118,643 (0.248%)
Mr. Walid Abi-Saab
116,700 (0.244%)
Dr. Robert Gut, M.D.,PhD
47,669 (0.100%)
Mr. Jack L. Kaye
34,119 (0.072%)
Dr. Jeremy P. Springhorn, PhD
25,987 (0.055%)
Mr. David D. Meek
22,481 (0.047%)
Ms. Paula Soteropoulos
22,423 (0.047%)

Funds Holdings

SPDR® S&P Biotech ETF
3,462,869 (7.239%)
Vanguard Institutional Extnd Mkt Idx Tr
661,919 (1.384%)
Columbia Small Cap Value Fund I
532,360 (1.113%)
AlphaCentric LifeSci Healthcare Fund
421,025 (0.880%)
iShares Biotechnology ETF
325,052 (0.679%)
Columbia VP Small Cap Value Fund
209,430 (0.438%)
Vanguard Health Care Index Fund
145,659 (0.304%)
BlackRock Extended Equity Market
107,056 (0.224%)
North Square Dynamic Small Cap Fd
96,010 (0.201%)
Fidelity Total Market Index Fund
79,824 (0.167%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices